Trial · NCT03204786
Results by group503
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 503
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in Parent Rated Social Responsiveness Scale, Second Edition (SRS-2) Total Scores During Treatment. | Vasopressin-Vasopressin | Total score - baseline | 81.3690 | Standard Error 2.1052 | T-score |
| Change From Baseline in Parent Rated Social Responsiveness Scale, Second Edition (SRS-2) Total Scores During Treatment. | Placebo-Vasopressin | Total score - baseline | 79.6795 | Standard Error 1.5448 | T-score |
| Change From Baseline in Parent Rated Social Responsiveness Scale, Second Edition (SRS-2) Total Scores During Treatment. | Placebo-Placebo | Total score - baseline | 82.2281 | Standard Error 1.5650 | T-score |
| Change From Baseline in Parent Rated Social Responsiveness Scale, Second Edition (SRS-2) Total Scores During Treatment. | Vasopressin-Vasopressin | Total score - change from baseline at 4-week | -5.6779 | Standard Error 1.6830 | T-score |
| Change From Baseline in Parent Rated Social Responsiveness Scale, Second Edition (SRS-2) Total Scores During Treatment. | Placebo-Vasopressin | Total score - change from baseline at 4-week | -4.5448 | Standard Error 1.2298 | T-score |
| Change From Baseline in Parent Rated Social Responsiveness Scale, Second Edition (SRS-2) Total Scores During Treatment. | Placebo-Placebo | Total score - change from baseline at 4-week | -6.4832 | Standard Error 1.2695 | T-score |
| Change From Baseline in Parent Rated Social Responsiveness Scale, Second Edition (SRS-2) Total Scores During Treatment. | Vasopressin-Vasopressin | Total score - 4-week | 75.0000 | Standard Error 2.1052 | T-score |
| Change From Baseline in Parent Rated Social Responsiveness Scale, Second Edition (SRS-2) Total Scores During Treatment. | Placebo-Vasopressin | Total score - 4-week | 74.7821 | Standard Error 1.5448 | T-score |
| Change From Baseline in Parent Rated Social Responsiveness Scale, Second Edition (SRS-2) Total Scores During Treatment. | Placebo-Placebo | Total score - 4-week | 74.8816 | Standard Error 1.5650 | T-score |
| Change From Baseline in Parent Rated Social Responsiveness Scale, Second Edition (SRS-2) Total Scores During Treatment. | Vasopressin-Vasopressin | Total score - change from week 4 at week 8 | -3.4420 | Standard Error 1.7758 | T-score |
| Change From Baseline in Parent Rated Social Responsiveness Scale, Second Edition (SRS-2) Total Scores During Treatment. | Placebo-Vasopressin | Total score - change from week 4 at week 8 | -5.3854 | Standard Error 1.2964 | T-score |
| Change From Baseline in Parent Rated Social Responsiveness Scale, Second Edition (SRS-2) Total Scores During Treatment. | Placebo-Placebo | Total score - change from week 4 at week 8 | -1.0443 | Standard Error 1.3267 | T-score |
| Change From Baseline in Parent Rated Social Responsiveness Scale, Second Edition (SRS-2) Total Scores During Treatment. | Vasopressin-Vasopressin | SCI score - baseline | 81.2500 | Standard Error 2.0892 | T-score |
| Change From Baseline in Parent Rated Social Responsiveness Scale, Second Edition (SRS-2) Total Scores During Treatment. | Placebo-Vasopressin | SCI score - baseline | 79.3333 | Standard Error 1.5330 | T-score |
| Change From Baseline in Parent Rated Social Responsiveness Scale, Second Edition (SRS-2) Total Scores During Treatment. | Placebo-Placebo | SCI score - baseline | 81.5987 | Standard Error 1.5531 | T-score |
| Change From Baseline in Parent Rated Social Responsiveness Scale, Second Edition (SRS-2) Total Scores During Treatment. | Vasopressin-Vasopressin | SCI score - change from baseline at 4-week | -5.6451 | Standard Error 1.6475 | T-score |
| Change From Baseline in Parent Rated Social Responsiveness Scale, Second Edition (SRS-2) Total Scores During Treatment. | Placebo-Vasopressin | SCI score - change from baseline at 4-week | -4.6366 | Standard Error 1.2024 | T-score |
| Change From Baseline in Parent Rated Social Responsiveness Scale, Second Edition (SRS-2) Total Scores During Treatment. | Placebo-Placebo | SCI score - change from baseline at 4-week | -6.3462 | Standard Error 1.2385 | T-score |
| Change From Baseline in Parent Rated Social Responsiveness Scale, Second Edition (SRS-2) Total Scores During Treatment. | Vasopressin-Vasopressin | SCI score - 4-week | 74.9405 | Standard Error 2.0892 | T-score |
| Change From Baseline in Parent Rated Social Responsiveness Scale, Second Edition (SRS-2) Total Scores During Treatment. | Placebo-Vasopressin | SCI score - 4-week | 74.3718 | Standard Error 1.5330 | T-score |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03204786/results